Chi-kong Y. Li
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia.
Journal: Cell reports. Medicine
Published: November 21, 2024
G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia.
Journal: Blood advances
Published: July 26, 2024
Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study.
Journal: European journal of haematology
Published: January 24, 2024
Molecular genetic characteristics of a family which coinheritance of rare-88 C>G (HBB:c.-138 C>G) β-thalassemia mutation with α-thalassemia and review of the literature
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: February 16, 2023
Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial.
Journal: American journal of hematology
Published: December 19, 2022
Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia.
Journal: Communications biology
Published: October 05, 2022
Examining patterns of traditional Chinese medicine use in pediatric oncology: A systematic review, meta-analysis and data-mining study.
Journal: Journal of integrative medicine
Published: July 09, 2021
Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
Journal: The Lancet. Oncology
Published: March 18, 2021
A novel F11 mutation in a Chinese paediatric patient with severe factor XI deficiency.
Journal: Thrombosis research
Published: December 04, 2019
Last Updated: 09/26/2026